This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Robert R. Schulze, MD
Des Moines, Iowa

JAMA. 1970;212(2):320.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

In reply to the recent communication "Extemporaneous Formulation of Corticosteroids for Topical Usage" by Burdick et al (219:462,1970), I would like to submit my solution for the problems which they encountered.

My favorite preparation of this type is a pharmaceutically elegant steroid for topical usage which is stable, very effective clinically, and at a cost to the patient of approximately 40% of the packaged and promoted counterpart. In addition, the physician has the advantage of being able to prescribe any strength steroid he desires and of being able to incorporate a keratolytic or antibiotic if indicated.

I submit the following formula for the consideration of your readers. With injectable triamcinolone acetonide (Kenalog) as the source of steroid and Lanophilic Ointment as the vehicle, this prescription is easily produced. Warming the base to a semiliquid state prior to the addition of the steroid insures even distribution and . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?